ProCyte's wound dressing cleared by FDA:
This article was originally published in Clinica
ProCyte has received clearance form the FDA to market its GraftCyte gauze wound dressings for use in hair follicle tranplantation during hair restoration. The dressings contain a copper peptide gel that provides nutrients for healing and revascularisation of hair follicle graft sites.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.